548 related articles for article (PubMed ID: 28401256)
1. Immune-mediated cytokine storm and its role in severe dengue.
Srikiatkhachorn A; Mathew A; Rothman AL
Semin Immunopathol; 2017 Jul; 39(5):563-574. PubMed ID: 28401256
[TBL] [Abstract][Full Text] [Related]
2. Understanding the contribution of cellular immunity to dengue disease pathogenesis.
Mathew A; Rothman AL
Immunol Rev; 2008 Oct; 225():300-13. PubMed ID: 18837790
[TBL] [Abstract][Full Text] [Related]
3. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections.
Kitab B; Kohara M; Tsukiyama-Kohara K
Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688
[TBL] [Abstract][Full Text] [Related]
4. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.
Talarico LB; Byrne AB; Amarilla S; Lovera D; Vázquez C; Chamorro G; Acosta PL; Ferretti A; Caballero MT; Arbo A; Polack FP
J Clin Virol; 2017 Dec; 97():10-17. PubMed ID: 29078078
[TBL] [Abstract][Full Text] [Related]
5. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
Her Z; Kam YW; Gan VC; Lee B; Thein TL; Tan JJ; ; Lee LK; Fink K; Lye DC; Rénia L; Leo YS; Ng LF
J Infect Dis; 2017 Jan; 215(1):42-51. PubMed ID: 28077582
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil Activation and Early Features of NET Formation Are Associated With Dengue Virus Infection in Human.
Opasawatchai A; Amornsupawat P; Jiravejchakul N; Chan-In W; Spoerk NJ; Manopwisedjaroen K; Singhasivanon P; Yingtaweesak T; Suraamornkul S; Mongkolsapaya J; Sakuntabhai A; Matangkasombut P; Loison F
Front Immunol; 2018; 9():3007. PubMed ID: 30687301
[TBL] [Abstract][Full Text] [Related]
7. Cytokine Expression in Dengue Fever and Dengue Hemorrhagic Fever Patients with Bleeding and Severe Hepatitis.
Imad HA; Phumratanaprapin W; Phonrat B; Chotivanich K; Charunwatthana P; Muangnoicharoen S; Khusmith S; Tantawichien T; Phadungsombat J; Nakayama E; Konishi E; Shioda T
Am J Trop Med Hyg; 2020 May; 102(5):943-950. PubMed ID: 32124729
[TBL] [Abstract][Full Text] [Related]
8. Dengue fever and dengue haemorrhagic fever: challenges of controlling an enemy still at large.
Kurane I; Takasaki T
Rev Med Virol; 2001; 11(5):301-11. PubMed ID: 11590668
[TBL] [Abstract][Full Text] [Related]
9. Plasma leakage in dengue haemorrhagic fever.
Srikiatkhachorn A
Thromb Haemost; 2009 Dec; 102(6):1042-9. PubMed ID: 19967133
[TBL] [Abstract][Full Text] [Related]
10. Early Detection of Plasma Leakage in Dengue Hemorrhagic Fever.
Nelwan EJ
Acta Med Indones; 2018 Jul; 50(3):183-184. PubMed ID: 30333266
[TBL] [Abstract][Full Text] [Related]
11. Evasion of the human innate immune system by dengue virus.
Pagni S; Fernandez-Sesma A
Immunol Res; 2012 Dec; 54(1-3):152-9. PubMed ID: 22569913
[TBL] [Abstract][Full Text] [Related]
12. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
[TBL] [Abstract][Full Text] [Related]
13. Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever.
Senaratne T; Wimalaratne H; Alahakoon DG; Gunawardane N; Carr J; Noordeen F
J Med Virol; 2016 Oct; 88(10):1703-10. PubMed ID: 26990973
[TBL] [Abstract][Full Text] [Related]
14. Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection.
Soe HJ; Manikam R; Raju CS; Khan MA; Sekaran SD
PLoS One; 2020; 15(8):e0237141. PubMed ID: 32764789
[TBL] [Abstract][Full Text] [Related]
15. Dengue haemorrhagic fever: a job done via exosomes?
Mishra R; Lata S; Ali A; Banerjea AC
Emerg Microbes Infect; 2019; 8(1):1626-1635. PubMed ID: 31711408
[TBL] [Abstract][Full Text] [Related]
16. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis.
Chaturvedi UC; Agarwal R; Elbishbishi EA; Mustafa AS
FEMS Immunol Med Microbiol; 2000 Jul; 28(3):183-8. PubMed ID: 10865168
[TBL] [Abstract][Full Text] [Related]
17. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
18. T cell responses and dengue haemorrhagic fever.
Screaton G; Mongkolsapaya J
Novartis Found Symp; 2006; 277():164-71; discussion 171-6, 251-3. PubMed ID: 17319161
[TBL] [Abstract][Full Text] [Related]
19. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
[TBL] [Abstract][Full Text] [Related]
20. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
